Imunon, Inc.
IMNN· Nasdaq
IMNNImunon, Inc.
Filed Aug 11, 2026 · 10-Q · 42 days after period end · 0001493152-26-036991
| Metric | Q2 2026 | Q2 2025 | Q2 2024 | Q2 2023 |
|---|---|---|---|---|
| Net Income | -$2.81M | -$2.74M | -$4.79M | -$5.56M |
| EPS Diluted | -$0.54 | -$2.15 | -$7.64 | -$0.61 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Imunon, Inc. · CIK 749647 · Engraved from SEC EDGAR
ended Jun 30, 2026 · filed Aug 11, 2026 · 42 d after period end
